ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 110 participants.
Also called NCT07371689
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 110 participants
- Registry
-
NCT07371689 -
2025-521478-32-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07371689. Randomized; quadruple masking; primary purpose treatment. Start 2026-02 (anticipated); primary completion 2029-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS
- Acronym
- ANAPEM
- Condition
- PEDIATRIC ACUTE MYOCARDITIS
- Intervention (Drug)
- Anakinra, KINERET®
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct07371689- Content hash
2625840336a392936866c2c62b95b42494961b19216805fda475b11c06720225